Who
Heather Ann McSharry
Director
Company insider
Files Form 4 as: Director, Jazz Pharmaceuticals.
In numbers
- Trades disclosed
- 49
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $3.8M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 9 May 2013
- Last trade
- 31 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $3,67015 at $244.64 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $444K1,840 at $241.39 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $3,67015 at $244.64 | filing |
| 31 Aug 2026filed 2 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $444K1,840 at $241.39 | filing |
| 5 Aug 2026filed 7 Aug 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,605 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,605 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $482K2,000 at $241.00 | filing |
| 22 May 2026filed 27 May 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $482K2,000 at $241.00 | filing |
| 20 Nov 2025filed 24 Nov 2025 | JAZZ Jazz Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,415 at $0.00 | filing |
| 20 Nov 2025filed 24 Nov 2025 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $472K3,415 at $138.08 | filing |
| 20 Nov 2025filed 24 Nov 2025 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $607K3,415 at $177.78 | filing |
| 8 Aug 2025filed 11 Aug 2025 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $218K1,959 at $111.25 | filing |
| 7 Aug 2025filed 11 Aug 2025 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,507 at $0.00 | filing |
| 6 Aug 2024filed 6 Aug 2024 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $179K1,608 at $111.35 | filing |
| 2 Aug 2024filed 6 Aug 2024 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,731 at $0.00 | filing |
| 14 Aug 2023filed 15 Aug 2023 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $186K1,344 at $138.16 | filing |
| 11 Aug 2023filed 15 Aug 2023 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,075 at $0.00 | filing |
| 8 Aug 2022filed 9 Aug 2022 | JAZZ Jazz Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —8,000 at $0.00 | filing |
| 8 Aug 2022filed 9 Aug 2022 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $180K1,179 at $152.32 | filing |
| 8 Aug 2022filed 9 Aug 2022 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $442K8,000 at $55.28 | filing |
News
Jazz Pharmaceuticals gets Cramer's vote of confidenceJAZZ · aol.com · 14 Oct 2026Critical Analysis: vTv Therapeutics (NASDAQ:VTVT) and Jazz Pharmaceuticals (NASDAQ:JAZZ)JAZZ · tickerreport.com · 12 Oct 2026Cramer's lightning round: 'I'm going to say yes to Jazz Pharmaceuticals'JAZZ · cnbc.com · 10 Oct 2026
0 headlines in the last 90 days name Heather Ann McSharry; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.